The global spinal biologics market is predicted to grow at a 3.75 percent compound annual growth rate, reaching $2.36 billion by 2021, according to a Research Cosmos report.
Biologics
Anika Therapeutics resumed distribution of its solid hyaluronic acid-based treatments after a voluntary, non-safety related recall in the second quarter.
AlloSource received a U.S. patent for its proprietary method to create ProChondrixCR, the company's fresh cryopreserved osteochondral allograft.
Bio2 Technologies is an orthobiologics company.
The global spine biologics market is projected to grow at a 3.5 percent compound annual growth rate to reach $2.72 billion by the end of 2025, according to a Market Reports World report.
Advertisement
Grand Junction, Colo.-based Vail-Summit Orthopaedics & Neurosurgery is using injectable plasma and stem cells to treat sports-related ligament and tendon injuries, according to an article written by William Sterett, MD, in Summit Daily.
Regenerative medicine company Osiris Therapeutics named Samson Tom as president and CEO.
SpinalCyte received FDA Investigational New Drug clearance for CybroCell, its fibroblast-based therapy to treat degenerative disc disease.
Researchers implanted tissue-engineered spinal discs in a goat model which provided long-term function, according to a study in Science Translational Medicine.
Stability Biologics provides allograft products for spine, orthopedic and wound care applications.